![Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets - European Journal of Cancer Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3e80ead5-6080-4962-bf3a-637d2737cffd/gr1_lrg.jpg)
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets - European Journal of Cancer
![JCM | Free Full-Text | Understanding COVID-19 Epidemiology and Implications for Control: The Experience from a Greek Semi-Closed Community | HTML JCM | Free Full-Text | Understanding COVID-19 Epidemiology and Implications for Control: The Experience from a Greek Semi-Closed Community | HTML](https://www.mdpi.com/jcm/jcm-10-02765/article_deploy/html/images/jcm-10-02765-g001.png)
JCM | Free Full-Text | Understanding COVID-19 Epidemiology and Implications for Control: The Experience from a Greek Semi-Closed Community | HTML
![Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/574cfded-2c30-425f-9f42-6c7ea066cb85/gr2a_lrg.jpg)